Personalized therapy for bone metastases should consider the patients’ remaining lifespan. Estimation of survival can be facilitated with scoring tools. A new tool was developed, specifically designed to estimate 12- month survival. | Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases